Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 6Neoplasms 2Pancreatic Neoplasms 1Liver Cirrhosis 1Infections 1Hepatitis D 1Hepatitis C, Chronic 1Hepatitis C 1Hepatitis B, Chronic 1Hepatitis B 1Fibrosis 1Esophageal and Gastric Varices 1Colonic Neoplasms 1

Interventions

Gemcitabine 69Fluorouracil 44pembrolizumab 43Oxaliplatin 42Capecitabine 40Bevacizumab 37Leucovorin 36Irinotecan 31Cisplatin 27Nivolumab 24Paclitaxel 21Cetuximab 21Panitumumab 20130-nm albumin-bound paclitaxel 20Sorafenib 18Albumin-Bound Paclitaxel 18Drug Therapy 15Docetaxel 15Cyclophosphamide 15Radiotherapy 14Blood Specimen Collection 14IFL protocol 12atezolizumab 11Exercise 11Taxes 10budigalimab 9Erlotinib Hydrochloride 9trametinib 8Folfox protocol 8Carboplatin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × peginterferon alfa-2a × Gastrointestinal × Clear all
NCT00178763 2011-03-03

FR-WB-TT

The University of Texas Health Science Center, Houston

Phase 2 Unknown
36 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00834860 2010-02-15

Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase 4 Unknown
179 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡